Showing results (221-230 of 260) with videos related to
Sort By:
Pageof 26
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 25, 2017
SDF-1/CXCR4 expression is an independent negative prognostic biomarker in patients with head and neck cancer after primary radiochemotherapyChiara De-Colle, Apostolos Menegakis, David Mönnich, et al.International Journal of Cancer|December 14, 2017
Heat shock protein 70 and tumor-infiltrating NK cells as prognostic indicators for patients with squamous cell carcinoma of the head and neck after radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)Stefan Stangl, Nikoletta Tontcheva, Wolfgang Sievert, et al.The Journal of Molecular Diagnostics : JMD|April 6, 2020
Comparison of GeneChip, nCounter, and Real-Time PCR-Based Gene Expressions Predicting Locoregional Tumor Control after Primary and Postoperative Radiochemotherapy in Head and Neck Squamous Cell CarcinomaStefan Schmidt, Annett Linge, Marianne Grosser, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2019
Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12Emmanouil Fokas, Michael Allgäuer, Bülent Polat, et al.Clinical and Translational Radiation Oncology|March 30, 2018
SDF-1/CXCR4 expression in head and neck cancer and outcome after postoperative radiochemotherapyChiara De-Colle, David Mönnich, Stefan Welz, et al.JAMA Oncology|November 18, 2021
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical TrialEmmanouil Fokas, Anke Schlenska-Lange, Bülent Polat, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2023
DNA-Methylome-Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary RadiochemotherapyBouchra Tawk, Katrin Rein, Christian Schwager, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 4, 2018
Comparison of detection methods for HPV status as a prognostic marker for loco-regional control after radiochemotherapy in patients with HNSCCAnnett Linge, Ulrike Schötz, Steffen Löck, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 9, 2022
Analyses of molecular subtypes and their association to mechanisms of radioresistance in patients with HPV-negative HNSCC treated by postoperative radiochemotherapyShivaprasad Patil, Bouchra Tawk, Marianne Grosser, et al.European Journal of Nuclear Medicine and Molecular Imaging|June 28, 2024
Whole pelvis vs. hemi pelvis elective nodal radiotherapy in patients with PSMA-positive nodal recurrence after radical prostatectomy - a retrospective multi-institutional propensity score analysisChristian Trapp, Daniel M Aebersold, Claus Belka, et al.Pageof 26